Talk to our Consultant - India Chronic Disease Management Solutions Market Size & outlook 2032

India Chronic Disease Management Solutions Market Research Report: Forecast (2026-2032)

India Chronic Disease Management Solutions Market - By Component (Solutions, Services), By Deployment Mode (On-Premise, Cloud-Based, Hybrid), By Delivery Mode (Web-Based Platforms, Mobile Applicatio... ... s, Mobile Application Platforms, Integrated Wearables & Devices, Telemonitoring Devices, Point-of-Care Devices), By Disease Indication (Diabetes, Cardiovascular Disease (CVD), Chronic Respiratory Diseases, Chronic Obstructive Pulmonary Disorders (COPD), Asthma, Cancer Care Management, Chronic Kidney Disease (CKD), Hypertension / Blood Pressure, Neurological Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Other Chronic Conditions), By Patient Age Group (Up to 20, 21 to 35, 36 to 50, 51 to 65, Above 65), By Patient Location (Urban, Rural), By Solution Type (Monitoring Solutions, Continuous Glucose Monitoring (CGM), Blood Pressure Monitoring, Respiratory Function Monitoring, Cardiac Rhythm Monitoring, Activity & Lifestyle Tracking, Management & Intervention Solutions, Medication Adherence Tools, Behavioral Therapy & Coaching Tools, Diet & Nutrition Management Systems, Exercise & Rehabilitation Management), By Technology (Artificial Intelligence (AI) / Machine Learning (ML), Internet of Things (IoT), Big Data & Predictive Analytics, Cloud Computing, Blockchain for Healthcare Data, Remote Monitoring Sensors, Mobile Technology Integration, Virtual Care / Telepresence Tech), By Buyers (Patients, Providers, Government, Insurers, Employers), By Care Type (Facility-Based Clinical Management, Home Care, Population Level Chronic Care Program, Others), and others Read more

Healthcare
Jan 2026
Pages 138
Report Format: PDF, Excel, PPT

India Chronic Disease Management Solutions Market Report Key Takeaways

The India Chronic Disease Management Solutions Market size was valued at around USD 689 million in 2025 and is projected to reach USD 1419 million by 2032. The estimated CAGR from 2026 to 2032 is around 10.87%, indicating strong growth.
By Patient Age Group, the 36 to 50 age group segment holds a 29% share of the India Chronic Disease Management Solutions Market size in 2025.
By Disease Indication, diabetes represented a 35% share of the India Chronic Disease Management Solutions Market size in 2025.
By Care Type, facility-based clinical management represented 67% of the India Chronic Disease Management Solutions Market size in 2025.
By Patient Location, the Urban segment seized around 57% share of the India Chronic Disease Management Solutions Market size in 2025.
By Region, North India leads the India Chronic Disease Management Solutions Market with a dominant share of around 34% share in 2025.
The leading chronic disease management solutions companies in India are BeatO, HealthifyMe, Wellthy Therapeutics, NanoHealth, Cipla, Nivaancare, Fitterfly, Sun Pharmaceuticals, Apollo Hospitals, and others.

Market Insights & Analysis: India Chronic Disease Management Solutions Market (2026-2032):

The India Chronic Disease Management Solutions Market was valued at around USD 689 million in 2025 and is projected to reach USD 1419 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 10.87% during the forecast period, i.e., 2026-32.

The India Chronic Disease Management Solutions Market is experiencing rapid growth, driven by propelled by a sharp increase in chronic disease prevalence and the growing deployment of AI-powered screening and predictive diagnostics. These advancements are enhancing patient monitoring, enabling earlier clinical intervention, and strengthening long-term care coordination nationwide.

Recent findings from the World Health Organization indicate that hypertension now affects more than 210 million adults in India, accounting for over 30% of the adult population, with prevalence rising due to demographic ageing and lifestyle transitions.

State-led public-health campaigns echo this trend. For instance, Chhattisgarh screened more than 7.5 million people for diabetes and high blood pressure in the first seven months of 2025, underscoring the scale of population-level risk assessment currently underway.

National datasets, including findings from the National Family Health Survey (NFHS-5) and government self-reported records, continue to reflect hypertension prevalence of around 32% and diabetes prevalence of nearly 14% among adults, alongside growing cases of cardiovascular disorders and chronic respiratory conditions.

Within this context, AI-enabled screening and predictive diagnostics are emerging as key growth accelerators for the CDM market. For example, under the National Tuberculosis Elimination Programme, AI-supported screening tools have already been applied to more than 162,000 individuals, leading to a 12–16% improvement in case detection compared with conventional methods. These deployments signal a broader governmental shift toward technology-supported surveillance, automated triage, and early-stage clinical intervention, which is expected to stimulate demand for digital monitoring platforms and integrated chronic-care solutions.

Future policy initiatives are also likely to reinforce this trajectory. For instance, in 2025, the Ministry of Health and Family Welfare launched the Intensified Special Non-Communicable Disease Screening Drive, targeting 100% screening of all Indians aged 30 years and above for diabetes, hypertension, and common cancers through door-to-door outreach by Accredited Social Health Activists and Auxiliary Nurse Midwives, with the programme expected to expand beyond 2025 through data-driven follow-ups and surveillance.

Continued alignment with the National Health Policy 2017, the National Programme for Prevention and Control of Non-Communicable Diseases, and Sustainable Development Goal Target 3.4 further strengthens long-term commitments to preventive care and integrated health delivery.

Facility-based clinical management accounted for 67% of the India Chronic Disease Management Solutions Market in 2025, reaffirming the central role of hospitals and specialty centers in coordinated, multidisciplinary chronic-care delivery. Meanwhile, urban patients represented 57% of market demand, driven by higher diagnosis rates, stronger digital-health adoption, and broader access to AI-enabled screening and specialty-care infrastructure.

Rising chronic-disease prevalence, coupled with expanding AI-enabled screening and proactive government initiatives, is expected to significantly accelerate the adoption of advanced Chronic Disease Management solutions, reinforcing their central role in India’s evolving, prevention-focused healthcare landscape.

India Chronic Disease Management Solutions Market Recent Developments:

December 2025: The Armed Forces Medical Services (AFMS) has begun rolling out an AI-based diabetic eye screening programme across cities such as Pune, Mumbai, Bengaluru, and Kochi to improve early detection of diabetic retinopathy, a leading cause of preventable blindness among diabetics. The initiative, using the MadhuNetrAI platform, enables automated retinal imaging and analysis to identify at-risk patients and connect them with care pathways.
February 2025: Lillia, an AI health tech startup, has introduced a clinically validated chronic disease management platform that combines artificial intelligence with expert human coaching to help individuals living with diabetes and related conditions achieve better health outcomes. The initiative was supported by a USD 1.7 million grant from the Qatar Research, Development, and Innovation Council to develop digital twin technology and predictive care capabilities.

India Chronic Disease Management Solutions Market Scope:

Category	Segments
By Component	Solutions,Services,
By Deployment Mode	On-Premise,Cloud-Based,Hybrid,
By Delivery Mode	Web-Based Platforms, Mobile Application Platforms, Integrated Wearables & Devices, Telemonitoring Devices, Point-of-Care Devices,
By Disease Indication	Diabetes, Cardiovascular Disease (CVD), Chronic Respiratory Diseases, Chronic Obstructive Pulmonary Disorders (COPD), Asthma, Cancer Care Management, Chronic Kidney Disease (CKD), Hypertension / Blood Pressure, Neurological Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Other Chronic Conditions,
By Patient Age Group	Up to 20, 21 to 35, 36 to 50, 51 to 65, Above 65,
By Patient Location	Urban, Rural,
By Solution Type	Monitoring Solutions, Continuous Glucose Monitoring (CGM), Blood Pressure Monitoring, Respiratory Function Monitoring, Cardiac Rhythm Monitoring, Activity & Lifestyle Tracking, Management & Intervention Solutions, Medication Adherence Tools, Behavioral Therapy & Coaching Tools, Diet & Nutrition Management Systems, Exercise & Rehabilitation Management,
By Technology	Artificial Intelligence (AI) / Machine Learning (ML), Internet of Things (IoT), Big Data & Predictive Analytics, Cloud Computing, Blockchain for Healthcare Data, Remote Monitoring Sensors, Mobile Technology Integration, Virtual Care / Telepresence Tech,
By Buyers	Patients, Providers, Government, Insurers, Employers,
By Care Type	Facility-Based Clinical Management, Home Care, Population Level Chronic Care Program, Others), and others

India Chronic Disease Management Solutions Market Drivers:

Rising Chronic Disease Burden Augmenting Market Growth

India’s steadily rising burden of chronic diseases is becoming a decisive driver for the expansion of Chronic Disease Management solutions. Official government health records indicate that Non-Communicable Diseases (NCDs), particularly hypertension and diabetes, now represent one of the country’s most significant public-health challenges.

In response, the Government of India launched the “75/25 Initiative” in 2023, which aims to place 75 million individuals diagnosed with hypertension or diabetes under standardized clinical care by December 2025.

Progress has been substantial by March 2025, 42.01 million hypertension patients and 25.27 million diabetes patients had already been enrolled in structured treatment pathways, underscoring the growing scale of long-term disease management in the country.

Government figures from early 2025 further highlight the expanding caseload, reporting more than 11.1 million newly diagnosed hypertension cases and 6.4 million newly identified diabetes cases brought under treatment during the first half of the year. These outcomes reflect intensified nationwide screening, stronger surveillance mechanisms, and increasing emphasis on the principle that “prevention is better than cure.”

The sustained rise in chronic disease prevalence is reinforcing the strategic importance of preventive care and structured disease monitoring in India. This driver is expected to significantly strengthen demand for advanced Chronic Disease Management solutions, making them integral to the country’s evolving healthcare ecosystem in the years ahead.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
India Chronic Disease Management Solutions Market Policies, Regulations, and Product Standards
India Chronic Disease Management Solutions Market Trends & Developments
India Chronic Disease Management Solutions Market Dynamics
1. Growth Drivers
2. Challenges
India Chronic Disease Management Solutions Market Hotspot & Opportunities
India Chronic Disease Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
    1. Solutions
    2. Services
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
    1. On-Premise
    2. Cloud-Based
    3. Hybrid
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
    1. Web-Based Platforms
    2. Mobile Application Platforms
    3. Integrated Wearables & Devices
    4. Telemonitoring Devices
    5. Point-of-Care Devices
  4. By Disease Indication – Market Size & Forecast 2022-2032, USD Million
    1. Diabetes
    2. Cardiovascular Disease (CVD)
    3. Chronic Respiratory Diseases
      1. Chronic Obstructive Pulmonary Disorders (COPD)
      2. Asthma
    4. Cancer Care Management
    5. Chronic Kidney Disease (CKD)
    6. Hypertension / Blood Pressure
    7. Neurological Disorders
    8. Gastrointestinal Disorders
    9. Musculoskeletal Disorders
    10. Other Chronic Conditions
  5. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
    1. Up to 20
    2. 21 to 35
    3. 36 to 50
    4. 51 to 65
    5. Above 65
  6. By Patient Location – Market Size & Forecast 2022-2032, USD Million
    1. Urban
    2. Rural
  7. By Solution Type – Market Size & Forecast 2022-2032, USD Million
    1. Monitoring Solutions
      1. Continuous Glucose Monitoring (CGM)
      2. Blood Pressure Monitoring
      3. Respiratory Function Monitoring
      4. Cardiac Rhythm Monitoring
      5. Activity & Lifestyle Tracking
    2. Management & Intervention Solutions
      1. Medication Adherence Tools
      2. Behavioral Therapy & Coaching Tools
      3. Diet & Nutrition Management Systems
      4. Exercise & Rehabilitation Management
  8. By Technology – Market Size & Forecast 2022-2032, USD Million
    1. Artificial Intelligence (AI) / Machine Learning (ML)
    2. Internet of Things (IoT)
    3. Big Data & Predictive Analytics
    4. Cloud Computing
    5. Blockchain for Healthcare Data
    6. Remote Monitoring Sensors
    7. Mobile Technology Integration
    8. Virtual Care / Telepresence Tech
  9. By Buyers – Market Size & Forecast 2022-2032, USD Million
    1. Patients
    2. Providers
    3. Government
    4. Insurers
    5. Employers
  10. By Care Type – Market Size & Forecast 2022-2032, USD Million
    1. Facility-Based Clinical Management
    2. Home Care
    3. Population Level Chronic Care Program
    4. Others
  11. By Region
    1. North India
    2. South India
    3. West India
    4. East India
  12. By Company
    1. Company Revenue Shares
    2. Competitor Characteristics
India Diabetes Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Cardiovascular Disease (CVD) Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Chronic Respiratory Diseases Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Cancer Care Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Chronic Kidney Disease (CKD) Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Hypertension / Blood Pressure Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Neurological Disorders Chronic Disease Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Gastrointestinal Disorders Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Musculoskeletal Disorders Management Solutions Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Component – Market Size & Forecast 2022-2032, USD Million
  2. By Deployment Mode – Market Size & Forecast 2022-2032, USD Million
  3. By Delivery Mode – Market Size & Forecast 2022-2032, USD Million
  4. By Patient Age Group – Market Size & Forecast 2022-2032, USD Million
  5. By Patient Location – Market Size & Forecast 2022-2032, USD Million
  6. By Solution Type – Market Size & Forecast 2022-2032, USD Million
  7. By Technology – Market Size & Forecast 2022-2032, USD Million
  8. By Buyers – Market Size & Forecast 2022-2032, USD Million
  9. By Care Type – Market Size & Forecast 2022-2032, USD Million
  10. By Region
India Chronic Disease Management Solutions Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profiles
  1. BeatO
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. HealthifyMe
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Wellthy Therapeutics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. NanoHealth
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Cipla
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Nivaancare
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Fitterfly
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Sun Pharmaceuticals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Apollo Hospitals
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying